Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.43 |
| ▸ | FABP7 | O15540 | 2/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | TLR2 | O60603 | 2/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | MDM4 | O15151 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL570371 | 0.88 | KMT2A (0.49) | KMT2AFABP5FABP7PPARGPPARA | |
| SCHEMBL29203790 | 0.81 | KMT2A (0.45) | KMT2AFABP5FABP7PPARGPPARA | |
| SCHEMBL415413 | 0.81 | KMT2A (0.45) | KMT2AFABP5FABP7PPARGPPARA | |
| SCHEMBL17339044 | 0.81 | KMT2A (0.45) | KMT2AFABP5FABP7PPARGPPARA | |
| SCHEMBL29203732 | 0.81 | KMT2A (0.45) | KMT2AFABP5FABP7PPARGPPARA | |
| SCHEMBL16583993 | 0.80 | KMT2A (0.51) | KMT2AFABP5FABP7CASP3TLR2 | |
| SCHEMBL148347 | 0.78 | ALDH1A1 (0.43) | KMT2A | |
| SCHEMBL2040433 | 0.78 | KMT2A (0.50) | KMT2AFABP5FABP7CASP3EPHX2 | |
| SCHEMBL3794900 | 0.75 | KMT2A (0.55) | KMT2ACASP3TLR2EPHX2MDM4 | |
| SCHEMBL14717015 | 0.75 | PPARG (0.46) | KMT2AFABP5FABP7PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1673113-B1 | IMPLANTS WITH ATTACHED SILYLATED THERAPEUTIC AGENTS | SMART TECH LP (US) | 2010-12-29 | — | — | EP | disclosed |
| US-7737251-B2 | Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders | CONJUCHEM BIOTECHNOLOGIES INC. (CA) | 2010-06-15 | — | — | US | disclosed |
| US-20090312259-A1 | LONG LASTING GLUCAGON-LIKE PEPTIDE 2 (GLP-2) FOR THE TREATMENT OF GASTROINTESTINAL DISEASES AND DISORDERS | CONJUCHEM BIOTECHNOLOGIES INC. | 2009-12-17 | — | — | US | disclosed |
| EP-1980572-A1 | Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders | ConjuChem Biotechnologies Inc. (CA) | 2008-10-15 | — | — | EP | disclosed |
| EP-1360202-B1 | LONG LASTING GLUCAGON-LIKE PEPTIDE 2 (GLP-2) FOR THE TREATMENT OF GASTROINTESTINAL DISEASES AND DISORDERS | CONJUCHEM BIOTECHNOLOGIES INC (CA) | 2008-05-21 | — | — | EP | disclosed |
| US-7268113-B2 | Long lasting growth hormone releasing factor derivatives | CONJUCHEM BIOTECHNOLOGIES INC. (CA) | 2007-09-11 | — | — | US | disclosed |
| US-20060286140-A1 | Implants with attached silylated therapeutic agents | SMART TECH LP | 2006-12-21 | — | — | US | disclosed |
| US-20060217304-A1 | Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders | CONJUCHEM, LLC | 2006-09-28 | — | — | US | disclosed |
| US-7112567-B2 | Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders | CONJUCHEM INC. (CA) | 2006-09-26 | — | — | US | disclosed |
| EP-1673113-A2 | IMPLANTS WITH ATTACHED SILYLATED THERAPEUTIC AGENTS | Wickstrom, Eric (US) | 2006-06-28 | — | — | EP | disclosed |
| WO-2005027990-A2 | IMPLANTS WITH ATTACHED SILYLATED THERAPEUTIC AGENTS | UNIV JEFFERSON (US) | 2005-03-31 | — | — | WO | disclosed |
| US-20040248782-A1 | Long lasting glucagon-like peptide2(glp-2)for the treatment of gastrointestinal diseases and disorders | CONJUCHEM, LLC | 2004-12-09 | — | — | US | disclosed |
| EP-1360202-A2 | LONG LASTING GLUCAGON-LIKE PEPTIDE 2 (GLP-2) FOR THE TREATMENT OF GASTROINTESTINAL DISEASES AND DISORDERS | ConjuChem, Inc. (CA) | 2003-11-12 | — | — | EP | disclosed |
| EP-1355941-A2 | LONG LASTING GROWTH HORMONE RELEASING FACTOR DERIVATIVES | ConjuChem, Inc. (CA) | 2003-10-29 | — | — | EP | disclosed |
| US-20030073630-A1 | Long lasting growth hormone releasing factor derivatives | CONJUCHEM, LLC | 2003-04-17 | — | — | US | disclosed |
| WO-2002066511-A2 | LONG LASTING GLUCAGON-LIKE PEPTIDE 2 (GLP-2) FOR THE TREATMENT OF GASTROINTESTINAL DISEASES AND DISORDERS | CONJUCHEM INC. (CA) | 2002-08-29 | — | — | WO | disclosed |
| WO-2002062844-A2 | LONG LASTING GROWTH HORMONE RELEASING FACTOR DERIVATIVES | CONJUCHEM INC. (CA) | 2002-08-15 | — | — | WO | disclosed |